14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.67 $7.64 Monday, 22nd Apr 2024 FATE stock ended at $4.78. This is 0.209% less than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 5.47% from a day low at $4.67 to a day high of $4.92.
90 days $4.40 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Feb 16, 2021 $104.50 $107.43 $100.71 $101.44 625 153
Feb 12, 2021 $100.66 $103.64 $98.88 $102.45 587 837
Feb 11, 2021 $105.14 $107.76 $101.83 $102.50 805 891
Feb 10, 2021 $106.17 $109.59 $100.37 $103.31 626 521
Feb 09, 2021 $108.20 $109.29 $104.39 $105.32 510 750
Feb 08, 2021 $105.74 $109.96 $104.96 $108.50 693 909
Feb 05, 2021 $104.97 $107.30 $102.19 $105.19 558 538
Feb 04, 2021 $100.69 $104.99 $99.51 $102.62 622 989
Feb 03, 2021 $99.20 $102.62 $97.03 $98.24 826 906
Feb 02, 2021 $96.00 $100.32 $95.00 $97.49 916 573
Feb 01, 2021 $91.71 $94.45 $90.25 $93.16 914 858
Jan 29, 2021 $91.29 $93.83 $87.76 $90.63 856 086
Jan 28, 2021 $87.58 $94.93 $87.01 $90.91 1 104 076
Jan 27, 2021 $89.61 $89.61 $80.51 $87.52 1 585 339
Jan 26, 2021 $96.74 $98.97 $89.04 $89.31 855 390
Jan 25, 2021 $97.75 $99.45 $92.61 $96.14 1 213 555
Jan 22, 2021 $97.87 $101.03 $96.80 $97.19 1 131 959
Jan 21, 2021 $110.45 $110.45 $99.44 $99.67 1 055 264
Jan 20, 2021 $116.02 $119.85 $107.56 $109.01 986 177
Jan 19, 2021 $115.69 $117.70 $113.26 $114.31 889 180
Jan 15, 2021 $116.38 $119.44 $111.70 $113.59 807 873
Jan 14, 2021 $114.47 $121.16 $114.16 $117.40 732 988
Jan 13, 2021 $113.21 $115.37 $112.02 $113.29 937 391
Jan 12, 2021 $112.33 $114.67 $108.93 $112.05 693 797
Jan 11, 2021 $114.01 $114.80 $107.40 $112.01 1 085 908
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT